ESTA
Get informed when a big investor buys or sells
+ FollowOvervalued by 203.4% based on the discounted cash flow analysis.
| Market cap | $2.14 Billion |
|---|---|
| Enterprise Value | $2.07 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.72 |
| Beta | 1.09 |
| Outstanding Shares | 30,121,685 |
| P/E Ratio | -55.55 |
|---|---|
| PEG | 190.23 |
| Price to Sales | 9.4 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 8.42 |
| Enterprise Value to EBIT | -101.4 |
| Enterprise Value to Net Income | -54 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.09 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5681▼ 3.14% |
|---|---|
| Total Calls | 298,900▼ 89.32% |
| Total Puts | 169,800▼ 89.88% |
Holdings and activity of institutional investors.
| Ownership % | 94.92%▲ 4.56% |
|---|---|
| Total Invested | $2.41B▲ 58.70% |
| Investors Holding | 208▲ 19.00% |
No data
Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfoli...